Citius Pharmaceuticals stock price
시티우스 파머슈티컬스NASDAQ:CTXR · Nasdaq · Healthcare$0.5316-1.59%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Citius Pharmaceuticals last closed at $0.5316 (-1.59%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 602 of 739 stocks in Healthcare.
About this company
Citius Pharmaceuticals last closed at $0.5316 (-1.59%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 602/739
Valuation grade B-
Related stocks
- IncyteCompetitor
급성 방사선 피부염 등 피부·면역질환 치료제 영역에서 경쟁 가능성이 있는 대형 바이오 기업
- AmgenCompetitor
염증·면역질환 및 주사제 개발 역량이 큰 대형 제약사로 유사 치료영역 경쟁
- PfizerCompetitor
병원용 항감염·항암·면역 치료제 전반에서 경쟁하는 대형 제약사
About Citius Pharmaceuticals
- What technical signals does Citius Pharmaceuticals (CTXR) have?
- Citius Pharmaceuticals current technical signals: no active technical signal.
- Is Citius Pharmaceuticals a cup-and-handle pattern?
- No. Citius Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Citius Pharmaceuticals?
- Market cap: $8.47M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 0.18×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Citius Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy